RT Book, Section
A1 Bond Cox, Mary Ellen
A2 Dieter, Robert S.
A2 Dieter, Raymond A.
A2 Dieter, Raymond A.
SR Print(0)
ID 1126489511
T1 Anticoagulants
T2 Venous and Lymphatic Diseases
YR 2011
FD 2011
PB McGraw-Hill Medical
PP New York, NY
SN 9780071601580
LK accesscardiology.mhmedical.com/content.aspx?aid=1126489511
RD 2024/04/20
AB Prevention  and  treatment  of  thrombus  with  anticoagulants  have  been  primary  goals  of  medicine  for  half  a  century.  Previously  known  as  antithrombotics,  current  guidelines  recommend  the  term  anticoagulants  because  of  the  multiple  effects  beyond  thrombin  inhibition.  1,2  Anticoagulants  can  be  divided  into  indirect  anticoagulants  including  unfractionated  heparin  (UFH),  low-  molecular-weight  heparin  (LMWH),  heparinoids  or  synthetic  heparins  or  direct  anticoagulants  including  direct  thrombin  inhibitors  (DTIs),  and  the  oral  vitamin  K  antagonist,  warfarin.1,2